{"url":"https://lda.senate.gov/api/v1/filings/565b651a-2c19-4091-9b17-490e33cbb8ec/","filing_uuid":"565b651a-2c19-4091-9b17-490e33cbb8ec","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/565b651a-2c19-4091-9b17-490e33cbb8ec/print/","filing_document_content_type":"text/html","income":null,"expenses":"1050000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennifer Barblan","dt_posted":"2024-10-21T20:15:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1801 PENNSYLVANIA AVENUE, NW","registrant_address_2":"SUITE 900","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":66,"url":"https://lda.senate.gov/api/v1/registrants/66/","house_registrant_id":30001,"name":"ABBOTT LABORATORIES","description":null,"address_1":"1801 PENNSYLVANIA AVENUE, NW","address_2":"SUITE 900","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SETH RADUS","contact_telephone":"+1 202-378-2020","dt_updated":"2026-07-26T15:03:24.712043-04:00"},"client":{"id":100021,"url":"https://lda.senate.gov/api/v1/clients/100021/","client_id":12,"name":"ABBOTT LABORATORIES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to PT/INR (Prothrombin Time/International Normalized Ratio) testing. Proposals related to heart failure technology.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":92747,"prefix":null,"prefix_display":null,"first_name":"ROSALYN","nickname":null,"middle_name":null,"last_name":"KUMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":91957,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"BARBLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals related to medical device reimbursement and coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":92747,"prefix":null,"prefix_display":null,"first_name":"ROSALYN","nickname":null,"middle_name":null,"last_name":"KUMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":91957,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"BARBLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals related to preserving critical medical supply chains.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":196,"name":"U.S. Agency for International Development (USAID)"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Proposals related to access to infant formula.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":91957,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"BARBLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":92747,"prefix":null,"prefix_display":null,"first_name":"ROSALYN","nickname":null,"middle_name":null,"last_name":"KUMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Public Law 115-97 The Tax Cuts and Jobs Act. Public Law 117-169 Inflation Reduction Act of 2022. Proposals to reform domestic and international tax structures.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Proposals related to third party litigation reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}